Las Vegas, NV4 Active Studies

Lung Cancer Clinical Trials in Las Vegas, NV

Find 4 actively recruiting lung cancer clinical trials in Las Vegas, NV. Connect with local research sites and explore new treatment options.

4
Active Trials
3
Sponsors
708
Enrolling

Recruiting Lung Cancer Studies in Las Vegas

RecruitingLas Vegas, NVNCT05973773

REZILIENT3 (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors)

The purpose of this study is to evaluate the safety and efficacy of zipalertinib in combination with standard first-line platinum-based chemotherapy compared to chemotherapy alone, in patients with lo...

272 participants
Taiho Oncology, Inc.
View Study Details
RecruitingLas Vegas, NVNCT05967689

A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.

The purpose of this study is to evaluate the safety, efficacy and pharmacokinetics (PK) of zipalertinib in participants with locally advanced or metastatic Non-Small Cell Lung Cancer (NSCLC) harboring...

224 participants
Taiho Oncology, Inc.
View Study Details
RecruitingLas Vegas, NVNCT06162572

Phase 1b/2 Platform Study of Select Immunotherapy Combinations in Participants With Advanced Non-small Cell Lung Cancer (NSCLC)

This is a Phase 1b/2 study evaluating the anti-PD1 antibody, cemiplimab, in combination with either S095018 (anti-TIM3 antibody), S095024 (anti-CD73 antibody), or S095029 (anti-NKG2A antibody) in adul...

176 participants
Servier Bio-Innovation LLC
View Study Details
RecruitingLas Vegas, NVNCT05271292

Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC.

This is a Phase 1b/2, single-arm, open-label, dose-escalation study including 2 stages: Phase 1b: Dose-Escalation Stage (Single-Dose and Consecutive-Dose Periods) Phase 2: recommended Phase 2 dose (...

36 participants
Chipscreen Biosciences, Ltd.
View Study Details

About Lung Cancer Clinical Trials in Las Vegas

Lung cancer is the leading cause of cancer death worldwide, starting in the cells of the lungs. The two main types are non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Treatments include surgery, chemotherapy, radiation, immunotherapy, and targeted drugs.

There are currently 4 lung cancer clinical trials recruiting participants in Las Vegas, NV. These studies are seeking a combined 708 participants. Research is being sponsored by Taiho Oncology, Inc., Servier Bio-Innovation LLC, Chipscreen Biosciences, Ltd.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Lung Cancer Clinical Trials in Las Vegas — FAQ

Are there lung cancer clinical trials in Las Vegas?

Yes, there are 4 lung cancer clinical trials currently recruiting in Las Vegas, NV. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Las Vegas?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Las Vegas research site will contact you about next steps.

Are clinical trials in Las Vegas free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Las Vegas studies also compensate for your time and travel.

What lung cancer treatments are being tested?

The 4 active trials in Las Vegas are testing new therapies including novel drugs, biologics, and treatment approaches for lung cancer.

Data updated March 2, 2026 from ClinicalTrials.gov